Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2016-07-07 Regulatory Filings
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
ResMed to Announce Fourth Quarter Fiscal Year 2016 Results 1
Regulatory Filings Classification · 95% confidence The document is a press release announcing the date and details of an upcoming earnings results announcement and webcast for ResMed's fourth quarter fiscal year 2016. It does not contain actual financial results or substantive financial data but rather informs investors and the public about when and how the earnings results will be released and discussed. The document length is short (2228 characters), and it serves as a notification rather than the report itself. According to the classification rules, such announcements are best classified as Earnings Release (ER) if they contain key highlights of results, but this document only announces the upcoming release and webcast without any financial data. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the earnings release event, not the earnings release itself or a transcript.
2016-07-07 English
Form 8K/A 31 pages 298.2KB
Audit Report / Information Classification · 95% confidence The document is a Form 8-K/A filing by ResMed Inc. dated June 9, 2016, amending a previous Form 8-K related to the acquisition of Brightree LLC. It includes detailed financial statements of the acquired business (Brightree LLC) for the year ended December 31, 2015, and unaudited pro forma combined financial information reflecting the acquisition. The presence of audited financial statements, pro forma financials, and auditor's consent indicates this is a regulatory filing providing financial information related to a significant corporate event (acquisition). Form 8-K/A is an amendment to a current report, not a full annual or quarterly report. The document is not an earnings release, management discussion, or proxy material. It is a standalone audit and financial information supplement related to the acquisition event. Therefore, the best fitting category is Audit Report / Information (AR). FY 2015
2016-06-09 English
ResMed FORM SD 10 pages 320.5KB
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals compliance for the reporting period January 1, 2015 to December 31, 2015. It includes detailed disclosures about the company's due diligence process, supply chain risk assessments, and results regarding conflict minerals sourcing. The document is not a general annual or quarterly financial report, nor is it an earnings release or management discussion. It is a regulatory filing required under SEC rules for conflict minerals disclosure. The length and detail confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers miscellaneous regulatory disclosures that do not fit other categories.
2016-05-31 English
Update - Dividend/Distribution - RMD 4 pages 34.8KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, currency, record date, ex-date, payment date, withholding tax rates, and exchange rates. It specifically updates a previous announcement regarding the foreign exchange rate for the upcoming dividend. The content focuses on dividend details and payment logistics rather than financial results or broader company performance. This matches the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related details for shareholders. The document length and content confirm it is the announcement itself, not a brief summary or a report publication notice.
2016-05-19 English
Form 10Q for QTR ended March 31, 2016 34 pages 301.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2016. It contains detailed financial statements including balance sheets, statements of income, cash flows, notes to financial statements, management's discussion and analysis, and other comprehensive financial information. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full quarterly report rather than an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2016
2016-05-01 English
Appendix 3B 8 pages 361.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about the issuance of securities, including the number of securities issued, class of securities, issue price, purpose of the issue, and dividend policy. The document references ASX rules and compliance requirements related to securities issuance. This type of document is a formal announcement related to capital changes, specifically new share issues or stock options. It is not a full financial report, earnings release, or management discussion. Therefore, the document fits the category of 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed issuance data, confirming it is not merely an announcement of a report but the actual issuance notice.
2016-05-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.